PodcastIntel
Sign in Get Started Free
All-In with Chamath, Jason, Sacks & Friedberg
All-In with Chamath, Jason, Sacks & Friedberg

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

Sep 29, 2025 · 30:40
Listen to Episode
✨ AI Summary
  • Eli Lilly CEO Dave Ricks discusses GLP-1 breakthroughs and pricing.
  • He shares his personal health regimen and insights on addiction.
  • Ricks touches on counterfeit products and biotech VC trends.

More from All-In with Chamath, Jason, Sacks & Friedberg

All-In with Chamath, Jason, Sacks & Friedberg
SpaceX IPO, Iran War Fallout, Quantum Bitcoin Hack, The Space Opportunity
Apr 3, 2026 · 01:20:32
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic's Generational Run, OpenAI Panics, AI Moats, Meta Loses Lawsuits
Mar 27, 2026 · 01:20:11
All-In with Chamath, Jason, Sacks & Friedberg
Are Psychedelics the Key to Living Forever? (ft. Bryan Johnson)
Mar 26, 2026 · 37:58
All-In with Chamath, Jason, Sacks & Friedberg
How Matt Mahan Thinks He Can Save California
Mar 23, 2026 · 01:17:13
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to All-In with Chamath, Jason, Sacks & Friedberg and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →